Success Metrics

Clinical Success Rate
100.0%

Based on 9 completed trials

Completion Rate
100%(9/9)
Active Trials
0(0%)
Results Posted
44%(4 trials)

Phase Distribution

Ph phase_4
2
18%
Ph not_applicable
6
55%
Ph phase_2
3
27%

Phase Distribution

0

Early Stage

3

Mid Stage

2

Late Stage

Phase Distribution11 total trials
Phase 2Efficacy & side effects
3(27.3%)
Phase 4Post-market surveillance
2(18.2%)
N/ANon-phased studies
6(54.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

9 of 9 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

11

all time

Status Distribution
Completed(9)
Other(2)

Detailed Status

Completed9
unknown2

Development Timeline

Analytics

Development Status

Total Trials
11
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 23 (27.3%)
Phase 42 (18.2%)
N/A6 (54.5%)

Trials by Status

completed982%
unknown218%

Recent Activity

0 active trials
Showing 5 of 11
completednot_applicable

Treatment of Knee Osteoarthritis With PAAG-OA

NCT04045431
completednot_applicable

nSTRIDE APS Versus Hyaluronic Acid for Knee Osteoarthritis

NCT03182374
unknownphase_4

Long-term Safety and Performance of KiOmedine CM-Chitosan Supplementation in Advanced Symptomatic Knee Osteoarthritis

NCT05214807
completednot_applicable

Innovative Tool to Analyse Synovial Fluid of Patients With Knee Ostearthritis After IA Injection of Synvisc-one®

NCT04321668
completedphase_2

A Phase 2 Study to Evaluate the Efficacy and Safety of JointStem in Treatment of Osteoarthritis

NCT02674399
View all 11 trials

Clinical Trials (11)

Showing 11 of 11 trials
NCT04045431Not Applicable

Treatment of Knee Osteoarthritis With PAAG-OA

Completed
NCT03182374Not Applicable

nSTRIDE APS Versus Hyaluronic Acid for Knee Osteoarthritis

Completed
NCT05214807Phase 4

Long-term Safety and Performance of KiOmedine CM-Chitosan Supplementation in Advanced Symptomatic Knee Osteoarthritis

Unknown
NCT04321668Not Applicable

Innovative Tool to Analyse Synovial Fluid of Patients With Knee Ostearthritis After IA Injection of Synvisc-one®

Completed
NCT02674399Phase 2

A Phase 2 Study to Evaluate the Efficacy and Safety of JointStem in Treatment of Osteoarthritis

Completed
NCT01771952Not Applicable

Randomized Evaluation of the Efficacy of Synvisc-One® for the Treatment of Patellofemoral Chondromalacia

Completed
NCT03328728Not Applicable

Cellular Matrix Device for the Treatment of Mild to Moderate Knee Osteoarthritis

Unknown
NCT03203408Not Applicable

Efficacy of OSTENIL PLUS (Hyaluronic Acid) Versus SYNVISC-ONE in Patients With Tibiofemoral Osteoarthritis

Completed
NCT02389452Phase 4

Study of Safety and Efficacy of 6 mL Synvisc-One (Hylan G-F 20) in Indian Patients With Symptomatic Osteoarthritis of Knee(s) After Initial and Repeat Treatment

Completed
NCT02686047Phase 2

Comparing One Intraarticular Injection of a Novel HYAJOINT Plus With Synvisc-One for the Treatment of Knee OA

Completed
NCT01134406Phase 2

Hydros Joint Therapy and Hydros-TA Joint Therapy for Pain Associated With Knee Osteoarthritis (OA)

Completed

All 11 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
11